Contact Us
United States - English
China - 简体中文China - 繁體中文Germany – DeutschJapan - 日本語Switzerland - FrançaisUnited States - English
Filter By
All Years

2015/01/09

WuXi PharmaTech Provides Update of 2014 Financial Guidance, to Present at J.P. Morgan Healthcare Conference

WuXi PharmaTech (NYSE: WX), a leading open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology, and medical device industries with operations in China and the United States, today announced that it has updated its 2014 financial guidance.

Read more

2015/01/05

WuXi Launches Mobile App to Enable Chemistry-on-the-Go

SHANGHAI, January 5, 2015 /PRNewswire/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology and medical device industries, with operations in China and the United States, announced the launch of WuXi V-Lab, the first mobile app available to the global research community in need of small-molecule compound synthesis. WuXi V-Lab allows customers to request organic compound synthesis through a mobile device with ease, speed, and flexibility. The application provides online functions for inquiry, quotation, order confirmation, project tracking, delivery confirmation, and payment. WuXi V-Lab can be downloaded to an Apple or Android mobile device at: http://www.wuxiapptec.com/WXVLab

Read more